General Information of Drug (ID: DMLMV7V)

Drug Name
TSHA-118 Drug Info
Indication
Disease Entry ICD 11 Status REF
CLN1 disease 5C56.1 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMLMV7V

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Plitidepsin DMJ8AUE Multiple myeloma 2A83 Phase 3 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Palmitoyl-protein thioesterase 1 (PPT1) TTSQC14 PPT1_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of Taysha Gene Therapies
2 Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B